ACC 23: Mini-Thoracotomy Vs Sternoctomy for Degenerative Valve Disease: The UK Mini-Mitral Study скачать в хорошем качестве

ACC 23: Mini-Thoracotomy Vs Sternoctomy for Degenerative Valve Disease: The UK Mini-Mitral Study

Mr Enoch Akowuah (James Cook University Hospital, Middlesborough, UK) joins us on-site at ACC's 2023 scientific sessions to discuss the findings of the UK Mini-Mitral trial (National Institute of Health Research). This study is a multicentre, expertise-based randomised controlled trial that aimed to compare the safety and effectiveness of a minimally-invasive thoracotomy compared to conventional sternotomy in treating patients with degenerative mitral valve disease. After surgery, patient outcomes were followed up for one year, whilst estimates of clinical and health-economic outcomes will continue to be reported for up to five years. The trial saw a 96% repair rate in both arms. Questions: -What is the importance of the UK Mini Mitral? -What were the main considerations regarding the design of this trial? -What were the baseline characteristics of the patients? -What data did you present at ACC.23? -How should these findings impact clinical practice? -What are the next steps? For more content from ACC.23/WCC and the Late-breaker Discussion series head to Late-Breaking Science Video Collection. Recorded on-site at ACC 2023, New Orleans. Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/?... This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster. Like us on Facebook:   / radcliffecardiology   Follow us on Twitter:   / radcliffecardio